Machielse Bernardus N M 4
4 · Omthera Pharmaceuticals, Inc. · Filed Apr 17, 2013
Insider Transaction Report
Form 4
Machielse Bernardus N M
Executive VP and COO
Transactions
- Conversion
Common Stock
2013-04-16+25,601→ 25,601 total - Conversion
Series B Convertible Preferred Stock
2013-04-16−35,722→ 0 total→ Common Stock (25,601 underlying)
Footnotes (2)
- [F1]Represents the total number of shares received upon conversion of shares of the Issuer's Series B Convertible Preferred Stock (the "Series B Shares").
- [F2]Effective upon the closing of the Issuer's initial public offering of its Common Stock, each Series B Share automatically converted at a ratio of 1.3953-to-1 into the number of shares of Common Stock shown in column 7. The Series B Shares had no expiration date.